KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Interest & Investment Income (2016 - 2017)

Historic Interest & Investment Income for TherapeuticsMD (TXMD) over the last 4 years, with Q2 2017 value amounting to $3832.0.

  • TherapeuticsMD's Interest & Investment Income rose 3384.56% to $3832.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $50592.0, marking a year-over-year increase of 216.48%. This contributed to the annual value of $10824.0 for FY2016, which is 3794.29% down from last year.
  • As of Q2 2017, TherapeuticsMD's Interest & Investment Income stood at $3832.0, which was up 3384.56% from $2863.0 recorded in Q2 2016.
  • TherapeuticsMD's Interest & Investment Income's 5-year high stood at $41617.0 during Q1 2016, with a 5-year trough of $2280.0 in Q4 2015.
  • Over the past 4 years, TherapeuticsMD's median Interest & Investment Income value was $6598.0 (recorded in 2014), while the average stood at $11347.8.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 7613.32% in 2015, then surged by 12479.88% in 2016.
  • Over the past 4 years, TherapeuticsMD's Interest & Investment Income (Quarter) stood at $9553.0 in 2014, then plummeted by 76.13% to $2280.0 in 2015, then increased by 25.57% to $2863.0 in 2016, then surged by 33.85% to $3832.0 in 2017.
  • Its Interest & Investment Income stands at $3832.0 for Q2 2017, versus $2863.0 for Q2 2016 and $41617.0 for Q1 2016.